MyRenalCare app trial increased outpatient capacity by 30%
A trial for MyRenalCare found that when patients with chronic kidney disease used the app outpatient capacity was increased, and associated costs decreased.
Back to Top
A trial for MyRenalCare found that when patients with chronic kidney disease used the app outpatient capacity was increased, and associated costs decreased.
Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.
NHS Golden Jubilee has carried out the second highest number of ROSA procedures across the UK, after reaching a landmark 100 orthopaedic joint replacements.
Jordan Sollof is joined by Ling Lee, a GP and digital trailblazer fellow in Derby, to discuss her experience as a Shuri Network Bursary holder.
Following a successful trial in its radiology department, Sunderland Royal Hospital has now rolled out digital portering task management software.
Accurx Self-Book, which helps GPs schedule and book appointments could save Ā£123.1 million over five years if scaled up nationally, an evaluation found.
A randomised control study has shown that using the Healum planning software and app significantly improves health outcomes for Type 2 diabetes patients.
More people with type 1 diabetes in England will be able to receive an āartificial
Today’s Coffee Time Briefing covers AstraZeneca’s new AI tool and figures on the impact of
New patient safety guidance from NHS England says that primary careās IT systems should automatically
Isle of Wight NHS Trust will launch a digital consent platform created by former Digital
Researchers at Kingās College London and Imperial College London have developed an AI algorithm that